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anglais
Many research projects in life sciences require purified biologically active
recombinant protein. In addition, different formats of a given protein may be needed
at different steps of experimental studies. Thus, the number of protein variants to be
expressed and purified in short periods of time can expand very quickly. We have
therefore developed a rapid and flexible expression system based on described
episomal vector replication to generate semi-stable cell pools that secrete
recombinant proteins. We cultured these pools in serum-containing medium to avoid
time-consuming adaptation of cells to serum-free conditions, maintain cell viability
and reuse the cultures for multiple rounds of protein production. As such, an
efficient single step affinity process to purify recombinant proteins from serum-
containing medium was optimized. Furthermore, a series of multi-cistronic vectors
were designed to enable simultaneous expression of proteins and their biotinylation
in vivo as well as fast selection of protein-expressing cell pools. Combining these
improved procedures and innovative steps, exemplified with seven cytokines and
cytokine receptors, we were able to produce biologically active recombinant
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